Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults

Clinical trial NCT00387738 · TERMINATED

Trial details

NCT number: NCT00387738
Sponsor: Dynavax Technologies Corporation
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Rhinitis, Allergic, Seasonal

Start date: 2006-04-01
Primary completion: 2007-05-01
Enrollment: 738

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.